A collaborative health care approach enhances patient outcomes and supports informed decision-making in antibiotic management.
Pharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.
Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes
The adjuvant therapy has demonstrated varied efficacy for patients.
Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.
Eculizumab (Soliris; Alexion), a C5 inhibitor preventing cleavage into C5a and C5b, is widely considered the first-line therapy for high-risk TA-TMA.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Nuances can lead to frequent areas of confusion.
Analyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.
BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
A single-center experience at a tertiary medical center precision medicine clinic provides insight.
Studies show a need for coordination between the VA health care system and non-VA health care practices to decrease confusion and duplication of services.
Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
Self-audits help onsite frontline pharmacy leaders and team members to assess compliance before an external surveyor enters their pharmacy to inspect medication use processes.
A diagnosis of Clostridioides difficile infection does not instantly require treatment, but new guidelines include recommendations for treatment when warranted.
Each therapy presents a different but effective treatment option.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
More cost effectiveness data is crucial in advocating for better insurance coverage in the United States.
Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
Members, as well as health plans, pharmacy benefit managers, plan sponsors, and reinsurers want to know how to fund these expensive treatments to ensure positive outcomes.
Pharmacists can provide resources, monitor medications, and extend compassionate support to patients experiencing mental health challenge.
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Precision oncology represents an evolution in therapeutic practice.
Implementing these standards can be logistically challenging.
Data show these cases pose some of the most significant threats to patients and health systems.